loader
Please Wait
Applying Filters...

AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 211641 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Sun Pharmaceutical Industries Limited

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biopharma Group offers CDMO services with expertise in contract R&D for dried products & liquid formulations.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 SUN PHARM (3)

    filter

    01 TABLET;ORAL (3)

    filter

    01 RX (3)

    filter

    01 DEFERASIROX (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DEFERASIROX

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    360MG
    2020-01-02
    211641
    DEFERASIROX
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DEFERASIROX

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    180MG
    2020-06-15
    211641
    DEFERASIROX
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DEFERASIROX

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; ORAL
    90MG
    2020-01-02
    211641
    DEFERASIROX
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 211641

    Looking for FDA Orange Book APPLICATION 211641 3

    19

    Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DEFERASIROX, with a corresponding application number 211641.

    Regulatory Information RX

    With a dosage strength 360MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2020-01-02

    Therapeutic Equivalence (TE) Code AB

    18

    Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DEFERASIROX, with a corresponding application number 211641.

    Regulatory Information RX

    With a dosage strength 180MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2020-06-15

    Therapeutic Equivalence (TE) Code AB

    17

    Sun Pharmaceutical Industries Limited, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DEFERASIROX, with a corresponding application number 211641.

    Regulatory Information RX

    With a dosage strength 90MG

    Dosage Form Route TABLET; ORAL

    Reference Listed Drug No

    Approved since 2020-01-02

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY